Stocks Overview

LAST PRICE
2.8700
TODAY'S CHANGE (%)
Trending Up0.1000 (3.6101%)

Bid / Lots
2.8100/ 2
Ask / Lots
3.0000/ 4
Open / Previous Close
2.8500 / 2.7700
Day Range
Low 2.8050
High 2.9200
52 Week Range
Low 2.1000
High 14.2200
Volume
458,996
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 2.77
Time	Volume	VSTM
09:32 ET	9634	2.84
09:36 ET	2400	2.8545
09:38 ET	3309	2.85
09:41 ET	1000	2.85
09:43 ET	3310	2.8837
09:45 ET	100	2.865
09:48 ET	303	2.8726
09:50 ET	527	2.86
09:52 ET	4016	2.85
09:56 ET	2361	2.82
09:57 ET	302	2.8249
09:59 ET	1444	2.82
10:01 ET	700	2.845
10:03 ET	200	2.83
10:08 ET	240	2.835
10:10 ET	200	2.83
10:12 ET	12746	2.82
10:14 ET	300	2.825
10:15 ET	1920	2.835
10:17 ET	400	2.835
10:19 ET	400	2.835
10:21 ET	1000	2.83
10:24 ET	300	2.83
10:26 ET	1400	2.825
10:28 ET	1000	2.825
10:30 ET	4414	2.83
10:32 ET	2288	2.83
10:33 ET	100	2.83
10:35 ET	1945	2.82
10:37 ET	1320	2.83
10:42 ET	600	2.835
10:44 ET	500	2.835
10:46 ET	200	2.835
10:48 ET	2200	2.835
10:50 ET	500	2.835
10:51 ET	1500	2.85
10:53 ET	900	2.865
10:55 ET	1218	2.85
10:57 ET	1849	2.845
11:00 ET	100	2.845
11:02 ET	3900	2.855
11:04 ET	500	2.855
11:06 ET	8556	2.86
11:08 ET	4800	2.87
11:09 ET	21413	2.8625
11:11 ET	15698	2.885
11:13 ET	24760	2.92
11:15 ET	2900	2.9
11:18 ET	2240	2.88
11:20 ET	2700	2.89
11:22 ET	100	2.89
11:24 ET	1635	2.88
11:26 ET	1118	2.885
11:27 ET	3100	2.8801
11:31 ET	826	2.885
11:36 ET	2105	2.885
11:38 ET	1373	2.9
11:42 ET	11321	2.88
11:44 ET	200	2.885
11:45 ET	6941	2.87
11:47 ET	700	2.875
11:49 ET	1100	2.875
11:54 ET	1704	2.875
11:56 ET	2161	2.88
11:58 ET	2550	2.885
12:00 ET	1001	2.885
12:03 ET	426	2.88
12:07 ET	252	2.88
12:09 ET	100	2.8816
12:12 ET	1594	2.885
12:14 ET	7866	2.89
12:18 ET	100	2.895
12:20 ET	7988	2.905
12:21 ET	1100	2.895
12:25 ET	4824	2.875
12:27 ET	300	2.865
12:30 ET	1631	2.87
12:34 ET	1536	2.875
12:36 ET	1400	2.875
12:38 ET	1723	2.885
12:39 ET	500	2.885
12:45 ET	100	2.88
12:50 ET	300	2.89
12:52 ET	15606	2.85
12:54 ET	7919	2.85
12:56 ET	600	2.85
12:57 ET	400	2.855
12:59 ET	100	2.854
01:01 ET	1326	2.835
01:03 ET	898	2.834
01:06 ET	2100	2.8301
01:08 ET	100	2.835
01:12 ET	1500	2.84
01:14 ET	100	2.835
01:15 ET	1400	2.835
01:17 ET	100	2.835
01:19 ET	200	2.835
01:21 ET	198	2.83
01:24 ET	1250	2.83
01:30 ET	1308	2.825
01:32 ET	702	2.82
01:33 ET	100	2.825
01:35 ET	10689	2.85
01:39 ET	3200	2.83
01:42 ET	800	2.83
01:44 ET	100	2.835
01:46 ET	326	2.835
01:48 ET	3696	2.845
01:50 ET	220	2.847055
01:51 ET	400	2.835
01:53 ET	200	2.8253
01:57 ET	800	2.825
02:00 ET	100	2.825
02:02 ET	3078	2.81
02:04 ET	279	2.8115
02:08 ET	1573	2.805
02:09 ET	2273	2.8135
02:11 ET	200	2.81
02:18 ET	2000	2.8103
02:20 ET	1100	2.815
02:22 ET	780	2.815
02:24 ET	710	2.81
02:26 ET	400	2.815
02:27 ET	200	2.815
02:29 ET	12487	2.825
02:31 ET	552	2.815
02:33 ET	1012	2.82
02:36 ET	1051	2.82
02:38 ET	100	2.825
02:40 ET	500	2.825
02:42 ET	300	2.825
02:44 ET	300	2.825
02:49 ET	3447	2.82
02:51 ET	624	2.815
02:54 ET	700	2.82
02:56 ET	200	2.815
02:58 ET	100	2.815
03:05 ET	408	2.815
03:07 ET	2385	2.825
03:09 ET	200	2.825
03:12 ET	700	2.825
03:14 ET	1399	2.815
03:16 ET	300	2.815
03:18 ET	405	2.81
03:20 ET	3595	2.83
03:21 ET	2400	2.835
03:23 ET	400	2.835
03:25 ET	1100	2.83
03:27 ET	800	2.83
03:30 ET	553	2.82
03:32 ET	3160	2.835
03:38 ET	4514	2.845
03:39 ET	200	2.84
03:41 ET	750	2.8414
03:48 ET	3383	2.835
03:50 ET	7826	2.845
03:52 ET	3029	2.85
03:54 ET	700	2.8517
03:56 ET	8995	2.85
03:57 ET	14775	2.85
03:59 ET	26644	2.87

Data delayed at least 15 minutes.

Sep 30, 2024
- DJ Verastem Initiated at Buy by Guggenheim, from 7:18AM ET on Monday Sep 30, 2024 by Dow Jones
  7:18AM ET on Monday Sep 30, 2024 by Dow Jones
Sep 10, 2024
- Verastem Oncology to Present at the 2024 Cantor Global Healthcare Conference, from 4:05PM ET on Tuesday Sep 10, 2024 by Dow Jones
  4:05PM ET on Tuesday Sep 10, 2024 by Dow Jones
- Verastem Oncology to Present Mature RAMP 201 Data in Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society 2024 Annual Meeting, from 7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
  7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesVSTM Verastem Inc	115.5M	-0.9x	---
United StatesACET Adicet Bio Inc	117.0M	-0.6x	---
United StatesNVCT Nuvectis Pharma Inc	113.8M	-4.7x	---
United StatesIVVD Invivyd Inc	113.5M	-0.5x	---
United StatesPRLD Prelude Therapeutics Inc	110.0M	-1.1x	---
United StatesANVS Annovis Bio Inc	109.8M	-1.9x	---
As of 2024-10-05

Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).

Contact Information

Headquarters: 117 Kendrick Street, Suite 500CAMBRIDGE, MA, United States 02494
Phone: 781-292-4200
Fax: 302-655-5049

Executives

President, Chief Executive Officer, Director: Daniel Paterson
Chief Financial Officer: Daniel Calkins
Independent Director: Paul Bunn
Independent Director: Anil Kapur
Independent Director: Michelle Robertson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$115.5M
Revenue (TTM)	$10.0M
Shares Outstanding	40.2M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.17
EPS	$-3.34
Book Value	$3.11
P/E Ratio	-0.9x
Price/Sales (TTM)	11.5
Price/Cash Flow (TTM)	---
Operating Margin	-987.84%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Verastem Inc
NASDAQ:VSTMUnited States

Search Criteria

Charts

Recent News

Sep 30, 2024

DJ Verastem Initiated at Buy by Guggenheim, from 7:18AM ET on Monday Sep 30, 2024 by Dow Jones

Sep 10, 2024

Verastem Oncology to Present at the 2024 Cantor Global Healthcare Conference, from 4:05PM ET on Tuesday Sep 10, 2024 by Dow Jones

Verastem Oncology to Present Mature RAMP 201 Data in Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society 2024 Annual Meeting, from 7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar